Cancer- Pay to Persist

“Cancer reframed as a configuration-space exploit using the Pay-to-Persist framework. Cancer cells found a way to lower metabolic costs (S[γ]), degrade coherent identity (R[γ]), and optimize for cell-level rather than organism-level persistence. Treatment strategy: close the exploits through metabolic targeting, differentiation therapy, and microenvironment normalization rather than just killing cells. Includes novel combination therapies, testable predictions, and clinical classification by exploit profile. Released under CC BY-SA 4.0 with viral open science requirements: any clinical trials, drug development, or commercial applications must publish results openly and share protocols. Cancer treatment must remain a commons.”